Biodesix, Inc. (BDSX)
| Market Cap | 211.75M |
| Revenue (ttm) | 76.97M |
| Net Income (ttm) | -31.74M |
| Shares Out | 27.73M |
| EPS (ttm) | -1.74 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 20,336 |
| Open | 7.84 |
| Previous Close | 7.87 |
| Day's Range | 7.41 - 7.84 |
| 52-Week Range | 6.52 - 31.99 |
| Beta | n/a |
| Analysts | Strong Buy |
| Price Target | 23.33 (+205.0%) |
| Est. Earnings Date | Nov 9, 2021 |
About BDSX
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung cancer continuum of care, such as Nodify XL2 and Nodify CDT tests to help physicians reclassify risk of malignancy in patients with suspicious lung nodules; and GeneStrat tumor profiling and VeriStrat immune profiling tests that provide physicians with timely results to facilitate treatment decisions. It also provides Bio-Rad SARS-CoV-2 ddPCR test, which is designed to detect the presence of infection by ...
Financial Performance
In 2020, Biodesix's revenue was $45.56 million, an increase of 85.55% compared to the previous year's $24.55 million. Losses were -$31.35 million, 2.03% more than in 2019.
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for Biodesix stock is "Strong Buy." The 12-month stock price forecast is 23.33, which is an increase of 204.97% from the latest price.
News
Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced that multiple data presentations will occur a...
Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that two abstrac...
Biodesix to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Ch...
Biodesix DeSoto Laboratory Receives both ISO 13485:2016 Certification and Accreditation from the College of American ...
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX). Today Biodesix announced that the Accreditation Committee of the College of American Pathologists (CAP) and Briti...
4 Stocks Insiders Are Buying
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.
Biodesix Announces Second Quarter 2021 Results and Highlights
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced its financial an...
Biodesix to Present at the Canaccord Genuity 41st Annual Growth Conference
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Chief Executive Officer of ...
Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will rel...
Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company, today announced in partnership with Seer, Inc. (NASDAQ: SEER)...
Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody Test
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced the broad commer...
Biodesix Partners with Datavant to Enhance Value of Lung Cancer Databank
BOULDER, Colo. & SAN FRANCISCO--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading lung cancer diagnostic solutions company, announced a strategic partnership with Datava...
First Patient Enrolled in Biodesix and Addario Lung Cancer Medical Institute Study Aiming to Predict Patient Survival...
SAN CARLOS, Calif. and BOULDER, Colo.
Biodesix to Present at the William Blair 41st Annual Growth Stock Conference
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced Scott Hutton, Ch...
Biodesix Announces First Quarter 2021 Results
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced financial and op...
Biodesix Announces Intent to Launch Liquid Biopsy Next Generation Sequencing Test with Unprecedented Turnaround Time
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, has announced their plan to add ...
Biodesix Announces Presentation on SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Comme...
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced in partnership w...
Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021
BOULDER, Colo.--(BUSINESS WIRE)---- $BDSX #patientsfirst--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will rel...
Biodesix Announces Presentation on Use of Biomarker-Based Risk Assessment to Inform Lung Nodule Management
BOULDER, Colo.--(BUSINESS WIRE)-- #patientsfirst--Pulmonary disease expert, Dr. Susan Garwood, is hosted by CHEST to discuss standardized risk assessment to inform lung nodule management
Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Pati...
BOULDER, Colo.--(BUSINESS WIRE)-- #patientsfirst--Biodesix releases new data at AACR annual meeting on the use of proteomic profiling to help guide physician treatment strategies for NSCLC patients.
Biodesix Announces Issuance of Two U.S. Patents, Expands Coverage of Diagnostic Methods to Improve Care for Cancer Pa...
BOULDER, Colo.--(BUSINESS WIRE)-- #patientsfirst--Biodesix receives two important U.S. patents for diagnostic methods, which seek to improve care for cancer patients.
Biodesix Announces Closing of New $30 Million Term Loan
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix announces the closing of a $30 million term loan.
Biodesix Announces Fourth Quarter and Full Year 2020 Results
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix releases fourth quarter and full year 2020 results
Biodesix to Report Fourth Quarter and Fiscal 2020 Financial Results on March 16, 2021
BOULDER, Colo.--(BUSINESS WIRE)-- #BDSX--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that it will release financial re...
Biodesix CEO Scott Hutton Selected as One of Top 25 Biotech CEOs of 2021
BOULDER, Colo.--(BUSINESS WIRE)-- #BDSX--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that The Healthcare Technology Re...
Biodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen Schools
BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that the company has partnered with Chica...